Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > South Africa Hospitalization Rate Plunges in Omicron Wave

<< Previous

Bullboard Posts

Next >>

Comment by Eoganachton Dec 19, 2021 4:49pm

382 Views

Post# 34245240

RE:RE:RE:South Africa Hospitalization Rate Plunges in Omicron Wave

From your mouth to God's ear.

enriquesuave wrote: In my opinion Omicron will be the last wave and very mild. A cold with sniffles. It will spread fast and we will finally get herd immunity. Yes I'm very optimistic, but that's what it looks like for now. We shall soon have more data on this.

<< Previous

Bullboard Posts

Next >>

BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient's Guide